Literature DB >> 24759101

A molecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism.

Yu Chih Liu1, Zhenjun Chen2, Michelle A Neller3, John J Miles3, Anthony W Purcell1, James McCluskey2, Scott R Burrows3, Jamie Rossjohn4, Stephanie Gras5.   

Abstract

Mutations within T cell epitopes represent a common mechanism of viral escape from the host protective immune response. The diverse T cell repertoire and the extensive human leukocyte antigen (HLA) polymorphism across populations is the evolutionary response to viral mutation. However, the molecular basis underpinning the interplay between HLA polymorphism, the T cell repertoire, and viral escape is unclear. Here we investigate the T cell response to a HLA-B*35:01- and HLA-B*35:08-restricted (407)HPVGEADYFEY(417) epitope from Epstein-Barr virus and naturally occurring variants at positions 4 and 5 thereof. Each viral variant differently impacted on the epitope's flexibility and conformation when bound to HLA-B*35:08 or HLA-B*35:01. We provide a molecular basis for understanding how the single residue polymorphism that discriminates between HLA-B*35:01/08 profoundly impacts on T cell receptor recognition. Surprisingly, one viral variant (P5-Glu to P5-Asp) effectively changed restriction preference from HLA-B*35:01 to HLA-B*35:08. Collectively, our study portrays the interplay between the T cell response, viral escape, and HLA polymorphism, whereby HLA polymorphism enables altered presentation of epitopes from different strains of Epstein-Barr virus.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Immunology; Major Histocompatibility Complex (MHC); Structural Biology; T Cell Receptor (TCR); X-ray Crystallography

Mesh:

Substances:

Year:  2014        PMID: 24759101      PMCID: PMC4059114          DOI: 10.1074/jbc.M114.563502

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations.

Authors:  Martin Hülsmeyer; Roman C Hillig; Armin Volz; Melanie Rühl; Werner Schröder; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

2.  The shaping of T cell receptor recognition by self-tolerance.

Authors:  Stephanie Gras; Scott R Burrows; Lars Kjer-Nielsen; Craig S Clements; Yu Chih Liu; Lucy C Sullivan; Melissa J Bell; Andrew G Brooks; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2009-01-22       Impact factor: 31.745

3.  T cell allorecognition via molecular mimicry.

Authors:  Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

4.  Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response.

Authors:  Melissa J Bell; Rebekah Brennan; John J Miles; Denis J Moss; Jacqueline M Burrows; Scott R Burrows
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

5.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.

Authors:  Fleur E Tynan; Scott R Burrows; Ashley M Buckle; Craig S Clements; Natalie A Borg; John J Miles; Travis Beddoe; James C Whisstock; Matthew C Wilce; Sharon L Silins; Jacqueline M Burrows; Lars Kjer-Nielsen; Lyudmila Kostenko; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2005-09-25       Impact factor: 25.606

6.  Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.

Authors:  J Sample; L Young; B Martin; T Chatman; E Kieff; A Rickinson; E Kieff
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Allelic polymorphism in the T cell receptor and its impact on immune responses.

Authors:  Stephanie Gras; Zhenjun Chen; John J Miles; Yu Chih Liu; Melissa J Bell; Lucy C Sullivan; Lars Kjer-Nielsen; Rebekah M Brennan; Jacqueline M Burrows; Michelle A Neller; Rajiv Khanna; Anthony W Purcell; Andrew G Brooks; James McCluskey; Jamie Rossjohn; Scott R Burrows
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

9.  Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours.

Authors:  D K Snudden; P R Smith; D Lai; M H Ng; B E Griffin
Journal:  Oncogene       Date:  1995-04-20       Impact factor: 9.867

10.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Authors:  Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; Stéphanie Gras; Takayuki Chikata; Nozomi Kuse; Solène Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Zaïna Aït Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

View more
  9 in total

1.  How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire.

Authors:  Sydney J Blevins; Brian G Pierce; Nishant K Singh; Timothy P Riley; Yuan Wang; Timothy T Spear; Michael I Nishimura; Zhiping Weng; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

Review 2.  Understanding the complexity and malleability of T-cell recognition.

Authors:  John J Miles; James McCluskey; Jamie Rossjohn; Stephanie Gras
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

3.  Prediction of peptide binding to a major histocompatibility complex class I molecule based on docking simulation.

Authors:  Takeshi Ishikawa
Journal:  J Comput Aided Mol Des       Date:  2016-09-13       Impact factor: 3.686

4.  Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.

Authors:  Emma J Grant; Tracy M Josephs; Sophie A Valkenburg; Linda Wooldridge; Margaret Hellard; Jamie Rossjohn; Mandvi Bharadwaj; Katherine Kedzierska; Stephanie Gras
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

5.  MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.

Authors:  Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

6.  Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.

Authors:  Michael S Hwang; Michelle S Miller; Puchong Thirawatananond; Jacqueline Douglass; Katharine M Wright; Emily Han-Chung Hsiue; Brian J Mog; Tihitina Y Aytenfisu; Michael B Murphy; P Aitana Azurmendi; Andrew D Skora; Alexander H Pearlman; Suman Paul; Sarah R DiNapoli; Maximilian F Konig; Chetan Bettegowda; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou; Sandra B Gabelli
Journal:  Nat Commun       Date:  2021-09-06       Impact factor: 17.694

Review 7.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

8.  Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.

Authors:  Trishna Manandhar; Heike Kunze-Schumacher; Trevor Huyton; Alexander A Celik; Rainer Blasczyk; Christina Bade-Doeding
Journal:  Immunogenetics       Date:  2016-01-12       Impact factor: 2.846

9.  Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.

Authors:  Smita S Chandran; Jiaqi Ma; Martin G Klatt; Friederike Dündar; Chaitanya Bandlamudi; Pedram Razavi; Hannah Y Wen; Britta Weigelt; Paul Zumbo; Si Ning Fu; Lauren B Banks; Fei Yi; Enric Vercher; Inaki Etxeberria; Watchain D Bestman; Arnaud Da Cruz Paula; Ilinca S Aricescu; Alexander Drilon; Doron Betel; David A Scheinberg; Brian M Baker; Christopher A Klebanoff
Journal:  Nat Med       Date:  2022-04-28       Impact factor: 87.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.